Collegium Pharmaceutical, Inc
COLL
Revenue
145.28M
▲353.00k▲0.2436%
3 Months ChangeAssets
1.05B
▼-60.86M▼-5.46%
3 Months ChangeLiabilities
836.81M
▼-55.28M▼-6.20%
3 Months ChangeFree Cash Flow
61.37M
▲33.87M▲123.20%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-04
Form 8-K
ID: 0001104659-24-096647
2024-08-08
Form 10-Q
ID: 0001558370-24-011586
2024-08-08
Form 8-K
ID: 0001558370-24-011583
2024-07-29
Form 8-K
ID: 0001104659-24-083126
2024-06-13
Form 8-K
ID: 0001104659-24-071070
2024-05-24
Form 8-K
ID: 0001104659-24-065119
2024-05-20
Form 8-K
ID: 0001104659-24-063396
2024-05-13
Form 8-K
ID: 0001104659-24-060235
2024-05-10
Form 8-K
ID: 0001104659-24-059656
2024-05-09
Form 10-Q
ID: 0001558370-24-007601